North America holds a prominent position in the deferasirox market due to the region’s advanced healthcare infrastructure, increasing awareness of iron overload disorders, and strong access to specialized treatment options. The rising prevalence of transfusion-dependent conditions, including thalassemia, sickle cell disease, and myelodysplastic syndromes, continues to drive demand for...
English
Arabic
French
Spanish
Portuguese
Deutsch
Turkish
Dutch
Italiano
Romaian
Portuguese (Brazil)
Greek